Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarvajit Chakravarty

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
The Journal of Pharmacology and Experimental Therapeutics|March 17, 2017
Dual Inhibition of Bruton's Tyrosine Kinase and Phosphoinositide-3-Kinase p110<i>δ</i> as a Therapeutic Approach to Treat Non-Hodgkin's B Cell MalignanciesJennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3KδBrahmam Pujala, Anil K Agarwal, Sandip Middya, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
The Journal of Pharmacology and Experimental Therapeutics|March 17, 2017
Dual Inhibition of Bruton's Tyrosine Kinase and Phosphoinositide-3-Kinase p110<i>δ</i> as a Therapeutic Approach to Treat Non-Hodgkin's B Cell MalignanciesJennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3KδBrahmam Pujala, Anil K Agarwal, Sandip Middya, et al.
Pageof 4